Major step toward an Alzheimer's vaccine
نویسندگان
چکیده
Quebec City, Canada (January 15, 2013) — A team of researchers from Université Laval, CHU de Québec, and pharmaceutical firm GlaxoSmithKline (GSK) has discovered a way to stimulate the brain's natural defense mechanisms in people with Alzheimer's disease. This major breakthrough, details of which are presented today in an early online edition of the Proceedings of the National Academy of Sciences (PNAS), opens the door to the development of a treatment for Alzheimer's disease and a vaccine to prevent the illness.
منابع مشابه
Challenges and Perspectives toward Development of more Effective Influenza Vaccine
Influenza viruses continue to be a major health threat in human and bird populations. The improvements in formulation and production level of the current influenza vaccines are not sufficient to afford complete protection. The continuous antigenic drifts and emergence of endemic and zoonotic strains make influenza vaccine planning difficult. Concern about the emergence of new influenza pandemic...
متن کاملArtículo De Revisión / Review Article
Alzheimer's disease: Toward the rational design of an effective vaccine. Enfermedad de Alzheimer: Hacia el diseño racional de una vacuna eficaz. SUMMARY The promising clinical results with the human monoclonal antibodies aducanumab and solanezumab targeting β-amyloidin Alzheimer's disease treatment, confirm both the amyloid cascade hypothesis and protective natural immunity, while strengthening...
متن کاملCloning and expression of porA gene as the first step of a vaccine candidate study against Neisseria meningitidis serogroup A infection
Introduction: Neisseria meningitidis is a major causative agent of bacterial septicemia and meningitis in human. PorA is a major component of the outer membrane of N. meningitidis and functions as a cationic Porin. This study aimed to clone and determine the expression of PorA as the first step for producing a proper antigen in a vaccine study against N. meningitidis. Methods: An approximately ...
متن کاملAltered levels of blood proteins in Alzheimer's disease longitudinal study: Results from Australian Imaging Biomarkers Lifestyle Study of Ageing cohort
INTRODUCTION A blood-based biomarker panel to identify individuals with preclinical Alzheimer's disease (AD) would be an inexpensive and accessible first step for routine testing. METHODS We analyzed 14 biomarkers that have previously been linked to AD in the Australian Imaging Biomarkers lifestyle longitudinal study of aging cohort. RESULTS Levels of apolipoprotein J (apoJ) were higher in ...
متن کاملExpression of Gp63 Gene from NIH Strain of Leishmania major in Pichia pastoris
Leishmaniasis is a major infectious disease of considerable public health in more than 86 countries around the world. Several approaches toward vaccine development against this disease have been taken. Glycoprotein (gp63) is conserved among diverse species of Leishmania and has induced immunological responses in murine models. Therefore, this glycoprotein has been considered as a second generat...
متن کامل